Effect of Adjustable Sodium Dialysis on Maintenance Hemodialysis Patients
Hong-yong Liu1, Li-biao Xie2, Yi-kui Song3, Yun-qiang Zhang1, Min-jia Li1*
1Blood purification center, The Third Affiliated Hospital, Sun Yat-Sen University, Yuedong Hospital, Meizhou city, Guangdong province 514700, China
2Blood purification center, Meizhou Second Hospital of Traditional Chinese Medicine, Meizhou city, Guangdong province 514700, China
3Blood purification center, Jiaoling County People's Hospital, Meizhou city, Guangdong province 514100, China
*Corresponding author: Min-jia Li, Blood purification center, The Third Affiliated Hospital, Sun Yat-Sen University, Yuedong Hospital, Meizhou city, Guangdong province 514700, China
Received Date: 15 June 2023
Accepted Date: 19 June 2023
Published Date: 21 June 2023
Citation: Liu H, Xie L, Song Y, Zhang Y, Li M, et al. (2023) Effect of Adjustable Sodium Dialysis on Maintenance Hemodialysis Patients. J Urol Ren Dis 08: 1337. https://doi.org/10.29011/2575-7903.001337
Abstract
Objectives: To explore the effect of adjustable sodium dialysis on weight gain and blood pressure during maintenance hemodialysis patients.
Methods: Thirty patients were enrolled in the study. The dialysis procedure consisted of four sessions using a constant sodium concentration of 140 mmol/L, followed by four sessions with an adjustable sodium concentration. The sodium concentration in the dialysate decreased gradually from 140 mmol/L at the start of dialysis to 135 mmol/L at the end. Baseline measurements included age, sex, serum sodium, chloride, albumin, ferritin, parathyroid hormone, and hemoglobin levels. Measurements included blood pressure, dry weight (in kilograms), interdialysis weight gain(IDWG), interdialysis body weight growth rate(IDWG%), blood pressure coefficient of variation, During each dialysis session. Four rounds of adjustable sodium dialysis have been completed to further evaluate serum sodium and chloride levels.Statistical comparisons were conducted to assess the differences in serum sodium, serum chloride, mean systolic blood pressure, mean diastolic blood pressure, IDWG, IDWG%, systolic blood pressure coefficient of variation, and diastolic blood pressure coefficient of variation.
Results: Following adjustable sodium dialysis, serum chloride decreased significantly from 102.07±4.60mmol/L (during constant sodium dialysis) to 100.37±4.88mmol/L (P=0.004). Moreover, IDWG decreased from 2.44±0.93kg (during constant sodium dialysis) to 2.18±0.90kg (P=0.000). Additionally, IDWG% was lower during adjustable sodium dialysis (4 times) at 3.88%±1.63% compared to constant sodium dialysis at 4.36%±1.75% (P=0.001).
Conclusion: After four sessions of adjustable sodium dialysis, there were reductions in serum chloride, IDWG, and IDWG% compared to the baseline measurements.
Keywords:Adjustable sodium; Blood pressure; Coefficient of variation; Daily Weight Gain; Interdialytic; Maintenance hemodialysis
List of Abbreviations: CV: Coefficient Of Variation; CVD: Cardiovascular Disease; IDHT: Intradialytic Hypertension; IDWG: Interdialytic Daily Weight Gain; IDWG%: Rate Of Interdialytic Daily Weight Gain; MHD: Maintenance Hemodialysis
Introduction
Maintenance Hemodialysis (MHD) is the predominant renal replacement therapy, with Cardiovascular Disease (CVD) being the primary complication and leading cause of mortality in MHD patients [1]. Intradialytic Hypertension (IDHT) occurs in 10%-15% of dialysis cases and is a significant contributor to CVD [2-4]. IDWG is defined as the disparity between the weight before the current dialysis session and the weight after the previous one. An IDWG of less than 2.5kg indicates satisfactory capacity management [5]. The IDWG% denotes the proportion of IDWG to dry weight, and it should be maintained at 4%-4.5% of the dry weight [6]. MHD patients commonly experience salt and water overload, resulting in elevated thirst and water consumption due to excessive sodium accumulation [7]. This exacerbates the occurrence of IDHT. Patients diagnosed with IDHT exhibit unfavorable short-term and long-term prognoses, along with increased mortality rates [8,9]. Reducing the sodium burden within the body has the potential to slow down the advancement of CVD by alleviating volume overload.
Methodology
Patient Recruitment and Methods
- Study participants: We selected a total of 30 MHD patients from The Third Affiliated Hospital, Sun Yat-Sen University, Yuedong Hospital, between March 2023 and May 2023.
- Inclusion criteria: Patients undergoing maintenance hemodialysis for a minimum of 3 months and without a tendency towards hypotension.
- Exclusion criteria: (1) Patients with a history of cerebrovascular accident; (2) Patients with heart failure (left ventricular ejection fraction <40%);
- Grouping of study participants: The participants underwent four sessions of dialysis using constant sodium concentration of 140mmol/L. Subsequently, four sessions of adjustable sodium dialysis were conducted, gradually reducing the sodium concentration in the dialysate from 140mmol/L at the start to 135mmol/L at the end of each session.
Baseline and Follow-up Data Collection
Baseline data included age and gender. Serum levels of sodium, chloride, albumin, ferritin, parathyroid hormone, and hemoglobin were assessed. Blood pressure (at 0h, 1h, 2h, 3h during dialysis and post-dialysis), dry weight (kg), IDWG, IDWG%, blood pressure Coefficient of Variation (CV). Four rounds of adjustable sodium dialysis have been completed to further evaluate serum sodium and chloride levels. The blood pressure CV was calculated using the formula: CV = (standard deviation/mean) x 100%.
Definition
Statistical Analyses
The data were analyzed using SPSS 22.0 software, and continuous variables were reported as Mean ± Standard Deviation (SD). Normally distributed measurement data were presented as x±s, while count data were expressed as percentages. The paired sample t-test was employed for statistical analysis.
Results
Baseline Characteristics of all the Patients
The baseline included a total of 30 participants, of which 18 were males (60%). The participants had a mean age of 60.6±11.44 years. Their albumin levels were 38.28±3.71 g/L, ferritin levels were 484.75±276.23 μg/L, parathyroid hormone levels were 383.33±413.05 pg/ml, and hemoglobin levels were 116.5±14.36 g/L (Table 1).
Age (Years) |
60.6±11.44 |
Gender, (% male) |
18 (60%) |
Albumin(g/L) |
38.28±3.71 |
Ferritin(μg/L) |
484.75±276.23 |
Parathyroid hormone(pg/ml) |
383.33±413.05 |
Hemoglobin(g/L) |
116.5±14.36 |
Table 1: Baseline data of subjects.
Analysis of Follow-Up Results
Following adjustable sodium dialysis, serum chloride levels decreased (100.37±4.88 mmol/L) compared to constant sodium dialysis (102.07±4.60 mmol/L) (P=0.004). IDWG showed a decrease (2.18±0.90 kg) compared to constant sodium dialysis (2.44±0.93 kg) (P=0.000). IDWG% was also lower (3.88±1.63%) than constant sodium dialysis (4.36±1.75%) (P=0.001). No statistically significant differences were observed in serum sodium levels, mean systolic blood pressure, mean diastolic blood pressure, systolic blood pressure variation, or diastolic blood pressure variation (P>0.05) (Table 2).
Variable |
Constant sodium |
Adjustable sodium |
t/χ2/Z |
P |
sodium(mmol/L) |
137.83±2.68 |
137.73±2.72 |
0.23 |
0.817 |
chlorine(mmol/L) |
102.07±4.60 |
100.37±4.88 |
3.10 |
0.004 |
Mean systolic blood pressure (mmHg) |
155.10±14.12 |
153.56±17.29 |
1.04 |
0.306 |
Mean diastolic blood pressure (mmHg) |
84.90±6.17 |
87.10±12.85 |
-1.23 |
0.229 |
IDWG(kg) |
2.44±0.93 |
2.18±0.90 |
3.99 |
0.000 |
IDWG% |
4.36%±1.75% |
3.88%±1.63% |
3.69 |
0.001 |
Variation of systolic blood pressure (%) |
7.81%±2.53% |
8.36%±2.85% |
-0.91 |
0.373 |
Variation of diastolic blood pressure (%) |
7.22%±2.84% |
7.39%±2.73% |
-0.26 |
0.794 |
Table 2: Comparison of patient indicators between constant sodium dialysis and adjustable sodium dialysis.
Discussion
The sodium concentration in patients undergoing MHD depends on the balance between dietary intake and dialysis clearance. Due to severe impairment or loss of kidney function, MHD patients are highly susceptible to sodium overload, as their kidneys cannot adequately maintain water and sodium balance [10]. Research has demonstrated a clear correlation between sodium intake and calorie intake in patients with end-stage renal disease, and strict limitations on dietary sodium intake may result in malnutrition [11]. Consequently, enhancing the clearance of sodium during dialysis plays a crucial role in ameliorating sodium overload among patients undergoing dialysis [12].
Currently, there are two modes available for selecting the concentration of dialysate Na+: constant sodium and adjustable sodium. The constant sodium mode is the most commonly used. During constant sodium dialysis, the two-way sodium transport process can result in heightened sodium activity and increased intracellular sodium concentration, ultimately impacting blood pressure [13]. Constant high sodium dialysis may cause sodium retention and an increase in intracellular sodium concentration, thereby reducing the likelihood of hypotension during dialysis. However, it can also result in complications like elevated blood pressure, increased IDWG%, and thirst [14]. Constant low sodium dialysis is advantageous for managing hypertension [15]; however, the reduced sodium concentration in the dialysate also heightens the risk of hypotension and muscle cramps [16].
This study employed the adjustable sodium model. The sodium concentration of the dialysate decreased gradually from 140mmol/L at the start of dialysis to 135mmol/L at the conclusion of the procedure. Following the treatment, there were reductions observed in IDWG, IDWG%, and serum chloride compared to constant sodium dialysis. These findings suggest that low sodium dialysis can mitigate weight gain between dialysis sessions. Nonetheless, there were no significant alterations observed in serum sodium, blood pressure, or blood pressure variability. This lack of change may be attributed to the short treatment duration of adjustable sodium, which may not have had sufficient time to impact serum sodium and blood pressure. This study demonstrates that gradually decreasing the sodium concentration of the dialysate can effectively reduce interdialytic weight gain when compared to a standard constant low-sodium dialysis approach.
Limitations of the study
This study is subject to limitations, such as a small sample size and a relatively short duration of adjustable sodium dialysis.
References
- Collins A J, Foley R N, Herzog C (2011) US renal data system 2010 annual data report[J]. American Journal of Kidney Diseases 57: A8.
- Inrig JK, Patel UD, Toto RD (2009) Association of blood pressure increases during hemodialysis with 2-year mortality in incident hemodialysis patients: a secondary analysis of the Dialysis Morbidity and Mortality Wave 2 Study. American Journal of Kidney Diseases 54: 881-890.
- Inrig JK, Oddone EZ, Hasselblad V (2007) Association of intradialytic blood pressure changes with hospitalization and mortality rates in prevalent ESRD patients. Kidney international 71: 454-461.
- Van Buren PN, Kim C, Toto RD (2012) The prevalence of persistent intradialytic hypertension in a hemodialysis population with extended follow-up. The International journal of artificial organs 35: 1031-1038.
- Lee S, Molassiotis A (2002) Dietary and fluid compliance in Chinese hemodialysis patients. International journal of nursing studies 39: 695-704.
- (2006) Peritoneal Dialysis Adequacy 2006 Work Group. Clinical practice guidelines for peritoneal adequacy, update 2006. American journal of kidney diseases: the official journal of the National Kidney Foundation 48: S91-S97.
- Kimura G, Gotch FA (1984) Serum sodium concentration and body fluid distribution during interdialysis: importance of sodium to fluid intake ratio in hemodialysis patients. The International Journal of Artificial Organs 7: 331-336.
- Farris AB, Colvin RB (2012) Renal interstitial fibrosis: mechanisms and evaluation in: current opinion in nephrology and hypertension. Current opinion in nephrology and hypertension 21: 289.
- Assimon MM, Flythe JE (2016) Intradialytic blood pressure abnormalities: the highs, the lows and all that lies between. American journal of nephrology 42: 337-350.
- D'Amico M, Locatelli F (2002) Hypertension in dialysis: pathophysiology and treatment. Journal of nephrology 15: 438-445.
- Dong J, Li Y, Yang Z (2010) Low dietary sodium intake increases the death risk in peritoneal dialysis. Clinical Journal of the American Society of Nephrology 5: 240-247.
- Weiner DE, Brunelli SM, Hunt A (2014) Improving clinical outcomes among hemodialysis patients: a proposal for a “volume first” approach from the chief medical officers of US dialysis providers. American journal of kidney diseases 64: 685-695.
- Boero R, Guarena C, Berto IM (1988) Erythrocyte Na, K pump activity and arterial hypertension in uremic dialyzed patients[J]. Kidney international 34: 691-696.
- Inrig JK (2010) Antihypertensive agents in hemodialysis patients: a current perspective[C]//Seminars in dialysis. Oxford, UK: Blackwell Publishing Ltd 23: 290-297.
- Hecking M, Karaboyas A, Saran R (2012) Predialysis serum sodium level, dialysate sodium, and mortality in maintenance hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). American journal of kidney diseases 59: 238-248.
- Geng X, Shi E, Wang S (2020) The efficacy and safety of low dialysate sodium levels for patients with maintenance hemodialysis: a systematic review and meta-analysis. International Journal of Surgery 79: 332-339.